PTC
LMAT icon

Petrus Trust Company’s LeMaitre Vascular LMAT Stock Holding History

Petrus Trust Company’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,926
Closed -$409K – 372
2025
Q2 		$409K Buy
+4,926
New +$412K 0.04% 190
2024
Q4 		– Sell
-2,368
Closed -$220K – 674
2024
Q3 		$220K Buy
+2,368
New +$205K 0.02% 502
2024
Q1 		– Sell
-7,930
Closed -$450K – 727
2023
Q4 		$450K Buy
7,930
+1,761
+29% +$92.3K 0.04% 266
2023
Q3 		$336K Buy
+6,169
New +$366K 0.04% 349
2020
Q3 		– Sell
-13,146
Closed -$347K – 327
2020
Q2 		$347K Buy
13,146
+4,192
+47% +$110K 0.04% 55
2020
Q1 		$223K Buy
8,954
+2,285
+34% +$70.6K 0.03% 81
2019
Q4 		$240K Buy
+6,669
New +$230K 0.04% 197
2019
Q3 		– Sell
-8,119
Closed -$227K – 315
2019
Q2 		$227K Buy
+8,119
New +$226K 0.04% 188

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Petrus Trust Company's LMAT Position: Q3 2025 in Review

Petrus Trust Company sold out of LeMaitre Vascular (LMAT) in Q3 2025, closing a stake of 4,926 shares — an estimated $409K sold.

Petrus Trust Company first reported a position in LMAT in Q2 2019 and held it in 8 quarters. The position peaked at $450K in Q4 2023. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2025.

  • Petrus Trust Company reported no remaining LeMaitre Vascular position as of Q3 2025 after selling out during the quarter.
  • Petrus Trust Company sold 4,926 LeMaitre Vascular shares in Q3 2025, an estimated $409K.
  • Petrus Trust Company first reported a position in LeMaitre Vascular in Q2 2019 and held it in 8 quarters.
  • Petrus Trust Company's LeMaitre Vascular position peaked at $450K in Q4 2023.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2025.

Based on Petrus Trust Company's 13F filing for Q3 2025, filed 14 Nov 2025.